Elutia (ELUT) Interest & Investment Income (2025 - 2026)

Elutia's (ELUT) quarterly Interest & Investment Income came in at $108000.0 in Q1 2026, up 158.7% year-on-year from $41747.9 in Q1 2025, and up 158.7% quarter-over-quarter from -$184000.0 in Q1 2025.

Elutia (ELUT) Interest & Investment Income (2025 - 2026) Analysis & Trends

Elutia has disclosed Interest & Investment Income across 2 years of filings, most recently posting $108000.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 106.00 Mn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 33.50 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 40.98 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Elutia 41.28 Mn 12.79 Mn 1.80 Mn 108,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 108,000.00
Mar 31, 2025 -184,000.00